The global sterilants market is expected to grow from USD 2,361.6 million in 2023 to USD 4,244.1 million by 2033, reflecting a CAGR of 6% during the forecast period. This positive market growth is driven by the increasing need for effective sterilization solutions in healthcare, pharmaceutical manufacturing, and various industrial applications.
Sterilization plays a critical role in preventing infection transmission, particularly in healthcare settings where surgical instruments and medical equipment need to be thoroughly disinfected. The rising incidence of infections due to contaminated instruments, surfaces, or skin contact is creating a heightened demand for sterilants that are both effective and compatible with different materials. Sporicidal agents and other sterilizing products are increasingly being sought after for their ability to kill bacteria, viruses, and other pathogens, reducing the risk of cross-contamination in both medical and industrial environments.
The advancements in sterilization technologies, along with growing concerns over infection control and hygiene, are expected to drive market demand in the coming years. Additionally, the increasing focus on healthcare-associated infections (HAIs) and stringent regulatory standards are pushing healthcare facilities and industries to adopt more effective sterilization practices, further boosting market growth.
Key Takeaways:
- The global sterilants market is forecast to grow from USD 2,361.6 million in 2023 to USD 4,244.1 million by 2033, at a CAGR of 6%.
- The rising prevalence of infections in healthcare settings is driving demand for effective sterilization solutions.
- Sporicidal agents and sterilants are essential in preventing infection transmission and ensuring patient and operational safety.
- Advancements in sterilization technologies and increased infection control awareness are key factors contributing to market growth.
Some of the key players in the Sterilants market are
- 3M Company
- Steris Plc.
- Cantel Medical Corporation
- Evonik Industries AG
- Arkema S.A.
- Thor Group
- Metrex Research, LLC
- Ecolab Inc.
- Solvay SA
- LANXESS
- Contec, Inc.
- OZU Corporation
- Cetylite, Inc.
- Veltek Associates, Inc.
- Whiteley Corporation
- Gul Biyoloji Laboratuvari
Recent Development
Many leading players are focusing on various market consolidation activities such as mergers, acquisitions, supply distribution partnerships, and launching new products, leading to high competitiveness in the market. Key manufacturers are keen to expand the market footprint of their key products and provide solutions to end users. For instance, many leading manufacturers nowadays provide customized solutions based on various end-user requirements.
- In October 2021, Astell Scientific launched the latest AstellBio Sink line of Effluent Decontamination Systems (EDS) capable of automatically sterilizing polluted wastewater before releasing it into the sewer system. By deactivating biological agents up to and including level 3, the AstellBio Sink is capable of deterring the spread of harmful organisms.
- Earlier this year, Sodexo announced its partnership with Ecolab Inc. to offer healthcare facilities and hospitals across the country the latest in infection prevention products and services. By utilizing Ecolab’s Bioquell hydrogen peroxide vapor technology, Protecta Plus, Sodexo’s unique program, offers an additional way to reduce the threat of infection.
- In 2020, in response to the pandemic situation, Lanxess launched a high-level disinfectant named Rely+On Virkon. The product will be highly effective on hard surfaces and equipment, which will help to reduce the contamination of surfaces.
Access the Full Report
Sterilants Market Segmentation by Category
By Product:
- Ethylene Oxide (EtO)
- Glutaraldehyde
- Hydrogen Peroxide Gas Plasma (HPGP)
- Vaporized Hydrogen Peroxide
- Immersion and Vapor Phase Peracetic Acid
- Others
By Form:
- Liquid
- Spray
By End-user:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Reference Laboratories
- Rehabilitation Centers
- Long Term Care Centers
- Critical Care Centers
- Pharmaceutical & Biotechnology Companies
- Academics and Research Institutes
- Homecare Settings
By Region:
- North America
- Latin America
- Europe
- The Middle East and Africa
- East Asia
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
